Press Release: Homology : Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass., Jan. 03, 2024
Read full article »
Homology is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases.
Read more